Who is sponsoring NCT07025304?

NCT07025304 is sponsored by Smith & Nephew, Inc..

What drugs are being tested in NCT07025304?

Interventions in NCT07025304: REFLEX ULTRA 45.

What condition does NCT07025304 study?

NCT07025304 studies Nasal Obstruction Due to Inferior Turbinate Hypertrophy.

Is NCT07025304 still recruiting?

NCT07025304 is currently recruiting now. Last updated 7 January 2026.

Last reviewed 2026-01-07 · How we verify

NCT07025304

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in China

Recruiting now NA Last updated 7 January 2026

What this trial tests

NA trial testing REFLEX ULTRA 45 in Nasal Obstruction Due to Inferior Turbinate Hypertrophy in 105 participants. Currently enrolling.

Timeline

2 July 2025

Primary endpoint
30 September 2026

30 June 2028

Quick facts

Lead sponsor	Smith & Nephew, Inc.
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	105
Start date	2 July 2025
Primary completion	30 September 2026
Estimated completion	30 June 2028
Sites	6 locations across China

Drugs / interventions tested

REFLEX ULTRA 45

Conditions studied

Nasal Obstruction Due to Inferior Turbinate Hypertrophy — all drugs for Nasal Obstruction Due to Inferior Turbinate Hypertrophy →

Sponsor

Smith & Nephew, Inc. — full company profile →

Who can join

Adults 18 to 65, any sex, with Nasal Obstruction Due to Inferior Turbinate Hypertrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a prospective, multi-center, post-market clinical study to evaluate the safety and effectiveness of REFLEX ULTRA 45 for the coblation inferior turbinate reduction in China. The study product is REFLEX ULTRA 45 (EIC4845-01/EICA4845-01). Also it needs to be performed with the controller system COBLATOR II or WEREWOLF. The sample size is 105 subjects with approximate 6 sites in China mainland.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Smith & Nephew, Inc. trials

Trials by the same sponsor.

NCT06916728 — A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Ca · enrolling by invitation
NCT06831448 — Human Participant Study of a Prototype Multilayer Foam Dressing on Intact Skin. · NA · completed
NCT06700850 — Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin · NA · completed
NCT06306716 — A Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds · terminated
NCT06319911 — AETOS Shoulder System · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07025304 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Smith & Nephew, Inc.
Last refreshed: 7 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07025304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing